Quantcast
Last updated on April 18, 2014 at 7:49 EDT

Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom

July 26, 2011

BARCELONA, Spain and GERRARDS CROSS, England, July 26, 2011 /PRNewswire/ –

Veeva Systems announced today that Daiichi Sankyo, one of the world’s
top 20 pharmaceutical companies, is replacing its legacy, on-premise
Customer Relationship Management (CRM) system with Veeva CRM in the UK.
Daiichi Sankyo will deploy Veeva CRM to all of its commercial teams in the
UK including integrated healthcare, specialty care, medical liaison
scientists, and head-office teams (i.e., marketing and medical) to drive
more effective customer engagement.

Daiichi Sankyo had outgrown its current CRM system, according to
executives. “Most of our customer-facing teams were only using the system as
a basic customer information repository,” said Dr. Simon Clough, managing
director for Daiichi Sankyo UK. “It lacked important functionality and so
became nothing more than an expensive database to record calls. We were
looking for a system that offered functionality well beyond just call
recording.”

After researching alternative CRM systems, Daiichi Sankyo decided on
Veeva CRM. “We’re all about innovation that leads to enhanced quality and
value for our customers,” said Clough. “We’ve adopted an innovative agenda
for advancing everything from our science to our interactions with
stakeholders, and Veeva CRM supports it perfectly. The system’s intuitive,
easy-to-use interface and rich functionality are part of our strategy for
strengthening customer engagements in the UK’s changing NHS environment.”

Daiichi Sankyo was also drawn to Veeva iRep, which is the first
integrated Pharma CRM and CLM solution designed for the Apple iPad. Clough
continued, “We recognised that the system’s closed-loop marketing functions
and the device’s beautiful presentation of multi-media content would support
more interactive customer engagements. With iRep, we expect that our account
specialists will be more connected, responsive, and effective.”

Veeva Systems has rapidly become the leading provider of Pharma CRM
solutions globally. Cloud-based, Veeva CRM requires no hardware or software
to purchase, scale or maintain. In addition, all Veeva customers benefit
from free, automatic upgrades so users are always on the most up-to-date
version of the software and benefit from the very latest compliance changes
and system enhancements. Changes can be made to the system instantly without
user retraining or additional third-party costs.

Bill Barone, head of learning & innovation at Daiichi Sankyo UK
concluded, “We are very excited to work with a pioneering CRM organisation.
Veeva is ahead of the curve and leading the market from an innovation
perspective.”

About Daiichi Sankyo

The Daiichi Sankyo Group is dedicated to the creation and supply of
innovative pharmaceutical products to address the diversified, unmet medical
needs of patients in both mature and emerging markets. The company was
created in 2005 through the merger of two traditional Japanese enterprises,
Daiichi and Sankyo. With net sales of nearly EUR7.3 billion, Daiichi Sankyo
is one of the world’s 20 leading pharmaceutical companies. While maintaining
its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia,
and bacterial infections, the Group is engaged in the development of
treatments for thrombotic disorders and focused on the discovery of novel
oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi
Sankyo Group has created a “Hybrid Business Model”, which will respond to
market and customer diversity and optimize growth opportunities across the
value chain.

The company’s world headquarters are in Tokyo. Its European base is
located in Munich. Daiichi Sankyo Europe has affiliates in 12 European
countries in addition to a global manufacturing site located in
Pfaffenhofen, Germany. For more information, please visit:
http://www.daiichisankyo.com or http://www.daiichi-sankyo.eu

About Veeva CRM
The Veeva CRM suite of applications, comprised of VBioPharma, iRep, VMobile,
and VInsights, is the pharmaceutical and biotechnology industry’s leading
cloud-based CRM solution. In addition, iRep has quickly become the
industry’s choice for closed loop marketing on the iPad. Only Veeva CRM
accommodates the unique needs of multiple commercial teams in a single
solution, improving user adoption and sales effectiveness, while reducing
cost and complexity. Veeva CRM is now the foundation on which the
pharmaceutical industry is innovating its sales and marketing models for the
future.

About Veeva Systems
Veeva Systems is the leader in cloud-based solutions for the global life
sciences industry. Committed to innovation, product excellence, and customer
success, Veeva has over 90 customers, ranging from the world’s largest
pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a
privately held company headquartered in the San Francisco Bay Area, with
offices in Philadelphia, Barcelona, Paris, Beijing, Shanghai, and Tokyo. For
more information, visit http://www.veevasystems.com.

Copyright (c) 2011 Veeva Systems. All rights reserved. Veeva and the
Veeva logo are registered trademarks of Veeva Systems. Veeva Systems owns
other registered and unregistered trademarks. Other names used herein may be
trademarks of their respective owners.

        Media Contact

        Selma Nawaz
        European Marketing Director
        Veeva Systems
        selma.nawaz@veevasystems.com

        Jo Taylor
        Communications Director
        Daiichi Sankyo
        joanne.taylor@daiichi-sankyo.co.uk

SOURCE Veeva Systems and Daiichi Sankyo


Source: newswire